Research & Development (Pharma & Healthcare)

Pharma & Healthcare R&D Reports

Research & Development (Pharma & Healthcare) Market Research Reports, Industry Analysis and Trends

 

Publication Single User License (PDF) Price
LAG-3 Antagonist -Pipeline Insights, 2015

LAG-3 Antagonist -Pipeline Insights, 2015

Date Published: Aug 24 2015
LAG-3 Antagonist- Pipeline Insights, 2015 report provides the in-depth analysis of the pipeline assets across the LAG-3 Antagonist. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The LAG-3 Antagonist Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.
 
$675.00
TIM-3 Antagonist -Pipeline Insights, 2015

TIM-3 Antagonist -Pipeline Insights, 2015

Date Published: Aug 24 2015
TIM-3 Antagonist- Pipeline Insights, 2015 report provides the in-depth analysis of the pipeline assets across the TIM-3 Antagonist. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The TIM-3 Antagonist Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.
 
$575.00
OX-40 Agonist -Pipeline Insights, 2015

OX-40 Agonist -Pipeline Insights, 2015

Date Published: Aug 24 2015
OX-40 Antagonist- Pipeline Insights, 2015 report provides the in-depth analysis of the pipeline assets across the OX-40 Antagonist. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The OX-40 AgonistReport helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.
 
$675.00
Pharmaceuticals Industry in India 2015 - 2020

Pharmaceuticals Industry in India 2015 - 2020

Date Published: Aug 19 2015
Indian pharmaceuticals market is expected to grow at a CAGR of 18% by 2020 driven by the aging and growing population, rising income levels, emerging medical conditions and new diseases.
Pharmaceuticals Industry in India is expected to be worth US$ 55.39 billion by 2020.
 
$5,000.00
Global & USA BioSimilar Market Analysis to 2021; BioBetters, Erythropoietin (EPO), Human Growth Hormone (HGH), Granulocyte Colony-Stimulating Factor (G-CSF), Anti-Tumor Necrosis Factor (Anti-TNF), Monoclonal Antibodies (MAbs), Insulins, Interferons

Global & USA BioSimilar Market Analysis to 2021; BioBetters, Erythropoietin (EPO), Human Growth Hormone (HGH), Granulocyte Colony-Stimulating Factor (G-CSF), Anti-Tumor Necrosis Factor (Anti-TNF), Monoclonal Antibodies (MAbs), Insulins, Interferons

Date Published: Aug 10 2015
$3,400.00
Global Collaborative R&D Terms & Agreements in Pharma, Biotech & Diagnostics 2010-2015

Global Collaborative R&D Terms & Agreements in Pharma, Biotech & Diagnostics 2010-2015

Date Published: Aug 4 2015
The Global Collaborative R&D Terms & Agreements in Pharma, Biotech & Diagnostics 2010-2015 report provides comprehensive understanding and unprecedented access to the collaborative R&D partnering deals and agreements entered into by the worlds leading healthcare companies.
 

Description

$2,995.00
Global Molecular Diagnostics 2010-2015: Deal trends, players, financials and forecasts

Global Molecular Diagnostics 2010-2015: Deal trends, players, financials and forecasts

Date Published: Aug 4 2015
Global Molecular Diagnostics 2010-2015 report provides comprehensive understanding and unprecedented access to the molecular diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies.
 

Description

$1,995.00
Global Diagnostics Partnering 2010-2015: Deal trends, players, financials and forecasts

Global Diagnostics Partnering 2010-2015: Deal trends, players, financials and forecasts

Date Published: Aug 4 2015
The Global Diagnostics Partnering 2010-2015: Deal trends, players, financials and forecasts report provides comprehensive understanding and unprecedented access to the diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies.
 

Description

$3,495.00
Global Injectable Drug Delivery Partnering 2010-2015

Global Injectable Drug Delivery Partnering 2010-2015

Date Published: Jul 30 2015
Provides understanding and access to the injectable drug delivery partnering deals and agreements entered into by the worlds leading healthcare companies.
 

Description

Injectable Drug Delivery Partnering 2010-2015 report provides understanding and access to the injectable drug delivery partnering deals and agreements entered into by the world’s leading healthcare companies.
Trends in injectable drug delivery partnering deals
$1,495.00
Global Targeted Drug Delivery Partnering 2010-2015

Global Targeted Drug Delivery Partnering 2010-2015

Date Published: Jul 30 2015
Provides understanding and access to the targated drug delivery partnering deals and agreements entered into by the worlds leading healthcare companies.
 

Description

Targeted Drug Delivery Partnering 2010-2015 report provides understanding and access to the targeted drug delivery partnering deals and agreements entered into by the world’s leading healthcare companies.
Trends in targeted drug delivery partnering deals
$1,495.00
Global Topical Drug Delivery Partnering 2010-2015

Global Topical Drug Delivery Partnering 2010-2015

Date Published: Jul 30 2015
Provides understanding and access to the topical drug delivery partnering deals and agreements entered into by the worlds leading healthcare companies.
 

Description

Topical Drug Delivery Partnering 2010-2015 report provides understanding and access to the topical drug delivery partnering deals and agreements entered into by the world’s leading healthcare companies.
Trends in topical drug delivery partnering deals
$1,495.00
Global Transdermal Drug Delivery Partnering 2010-2015

Global Transdermal Drug Delivery Partnering 2010-2015

Date Published: Jul 30 2015
Provides understanding and access to the transdermal drug delivery partnering deals and agreements entered into by the worlds leading healthcare companies.
 

Description

Transdermal Drug Delivery Partnering 2010-2015 report provides understanding and access to the transdermal drug delivery partnering deals and agreements entered into by the world’s leading healthcare companies.
Trends in transdermal drug delivery partnering deals
$1,495.00
LAG-3 Antagonists, TIM-3 Antagonists & OX40 Agonists -Pipeline Insights, 2015

LAG-3 Antagonists, TIM-3 Antagonists & OX40 Agonists -Pipeline Insights, 2015

Date Published: Jul 28 2015
DelveInsight’s, LAG-3 Antagonists, TIM-3 Antagonists & OX40 Agonists- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the LAG-3 Antagonists, TIM-3 Antagonists & OX40 Agonists. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals.
$1,250.00
Nonalcoholic Steatohepatitis (NASH) - Pipeline Analysis

Nonalcoholic Steatohepatitis (NASH) - Pipeline Analysis

Date Published: Jul 17 2015
 “Nonalcoholic steatohepatitis (NASH) Pipeline Analysis” gives comprehensive insight on the various drugs being developed for the treatment of NASH. The report covers all the drugs being developed in various phases (Discovery, Preclinical & Clinical development). The pipeline focuses on novel medicines covering small molecules, monoclonal antibodies, Recombinant proteins and RNA-based therapeutics, but excludes Off-label, symptom relief drugs, generic combinations.
$3,600.00
Life Cycle Management Strategies - Optimizing revenues and defending generic competition

Life Cycle Management Strategies - Optimizing revenues and defending generic competition

Date Published: Jul 2 2015
Life Cycle Management Strategies Optimizing revenues and defending generic competition discusses various stages of product lifecycle management (LCM), Developmental, commercial and legal LCM strategies, objectives, benefits, factors impacting the choice of lifecycle management strategies, and keys to successful implementation of the strategies. The report provides detailed case studies for each of the key strategies such as indication expansion, reformulation, fixed-dose combinations, pricing strategies and so on.
$2,995.00
Chimeric Antigen Receptor (CAR) T cell Immunotherapy- Competitive Landscape, Technology and Pipeline Analysis, 2015

Chimeric Antigen Receptor (CAR) T cell Immunotherapy- Competitive Landscape, Technology and Pipeline Analysis, 2015

Date Published: Jul 1 2015
$1,750.00
Trends in Therapeutic Partnering 2010-2015

Trends in Therapeutic Partnering 2010-2015

Date Published: Jul 1 2015
Provides a detailed understanding and analysis of the 35 most popular therapeutic targets for partnering in the period 2010 to mid 2015
 

Description

The Trends in Therapeutic Partnering 2010-2015 report provides the most comprehensive and in-depth insight into the 35 most popular therapeutic targets for partnering in the period 2010 to mid 2015.
 
$3,995.00
Global Cancer Diagnostics Partnering 2010-2015: Deal trends, players, financials and forecasts

Global Cancer Diagnostics Partnering 2010-2015: Deal trends, players, financials and forecasts

Date Published: Jul 1 2015
The Global Cancer Diagnostics Partnering 2010-2015 report provides comprehensive understanding and unprecedented access to the cancer diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies.
 

Description

The Global Cancer Diagnostics Partnering 2010-2015 report provides an understanding and access to the cancer diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies.
$2,995.00
Global Cancer Vaccine Partnering 2010-2015: Deal trends, players, financials and forecasts

Global Cancer Vaccine Partnering 2010-2015: Deal trends, players, financials and forecasts

Date Published: Jul 1 2015
The Global Cancer VaccinenPartnering 2010-2015: Deal trends, players, financials and forecasts provides comprehensive understanding and unprecedented access to the cancer vaccine partnering deals and agreements entered into by the worlds leading healthcare companies.
 

Description

$1,995.00
Global Joint Venture Partnerships in Pharma, Biotech and Diagnostics 2010-2015

Global Joint Venture Partnerships in Pharma, Biotech and Diagnostics 2010-2015

Date Published: Jul 1 2015
The Global Joint Venture Partnerships in Pharma, Biotech and Diagnostics 2010-2015 report provides comprehensive understanding and unprecedented access to the joint venture partnering agreements entered into by the worlds leading healthcare companies.
 

Description

$1,995.00

Pages

Shopping cart

0 Items $0.00
Not able to find what you are looking for?
Call Us
WHY CHOOSE MARKET RESEARCH REPORTS?
1
Trusted By Leaders
2
Shop With Confidence
3
Customer Centric
4
Personalized Solutions
5
Secure Checkout

User login

Clients Who Trust Us

Orange, Google, Microsoft, Barclays, CassidianIntel, TPG, Elit Net, Cross Business Producers, AcmavolpakP&G, Cisco, Gemalto, General Insurance Corporation of India, Aviva, Cognizant, InoxWindB. Braun, Cobham, fiserv, Harris, Wipro, AonAl Meera, Nomura Research Institute, Tata Consultancy Services, Amara Raja, Hiranandani EnergyMunich Re, Lotte Chemical, National Post, First Data